GUARANTY
Exhibit 10.3
This GUARANTY (this “Guaranty”) dated as of March 19, 2024 is made by AEON Biopharma Sub, Inc., a Delaware corporation (“Guarantor”), in favor and for the benefit of Daewoong Pharmaceutical Co., LTD., a company organized and existing under the laws of the Republic of Korea (“Purchaser”).
Reference is made to (i) that certain Subscription Agreement dated as of the date hereof (as amended, restated, modified or supplemented from time to time, the “Purchase Agreement”; all capitalized terms used and not otherwise defined herein shall have the respective meanings ascribed to them in the Purchase Agreement) pursuant to which the Purchaser desires to purchase from AEON Biopharma, Inc., a Delaware corporation and parent corporation of Guarantor (the “Company”), two convertible promissory notes (collectively, the “Notes”) in the aggregate initial principal amount of $15,000,000.
In consideration of the substantial direct and indirect benefits derived by Guarantor from the transactions under the Purchase Agreement and the Notes, and in order to induce Purchaser to enter into the Purchase Agreement and purchase the Notes, the parties hereto hereby agree as follows:
[signature page follows]
IN WITNESS WHEREOF, each of the parties hereto has executed this guaranty as of the day and year first above written.
GUARANTOR:
AEON BIOPHARMA Sub, Inc.
By: /s/ Xxxx Xxxxx
Name: Xxxx Xxxxx
Title: Chief Executive Officer
Address: 0 Xxxx Xxxxx, Xxxxx 0000, Xxxxxx, XX 00000
PURCHASER:
Daewoong PHARMACEUTICAL co., ltd.
By: /s/ Xxxxxx Xxxx
Name: Xxxxxx Xxxx
Title: President & CEO
Address: 00, Xxxxxxxxx-xx 000, Xxxxxxx-xx, Xxxxx
The undersigned hereby acknowledges receipt of a copy of the foregoing Guaranty and consents to the terms thereof, as of the date first above written.
By: /s/ Xxxx Xxxxx
Name: Xxxx Xxxxx
Title: President and Chief Executive Officer
Address: 0 Xxxx Xxxxx, Xxxxx 0000, Xxxxxx, XX 00000